The use of 1540 nm fractional photothermolysis for the treatment of acne scars in Asian skin: a pilot study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Kwang Ho | - |
dc.contributor.author | Ahn, Ji Young | - |
dc.contributor.author | Kim, Ji Young | - |
dc.contributor.author | Li, Kapsok | - |
dc.contributor.author | Seo, Seong Jun | - |
dc.contributor.author | Hong, Chang Kwun | - |
dc.date.available | 2019-05-30T02:58:10Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.issn | 0905-4383 | - |
dc.identifier.issn | 1600-0781 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/23141 | - |
dc.description.abstract | Various modalities have been used to treat acne scars, but limited efficacy and considerable side effects have restricted their proper use. Recently, a new-generation fractional photothermolysis modality has been introduced that has deeper penetrating ability; however, a 1540 nm fractional photothermolysis study has not yet been performed. To evaluate the efficacy and safety of 1540 nm fractional photothermolysis for the treatment of acne scars in Asian skin. Sixteen volunteers (Fitzpatrick skin types III-IV) with mild to moderate acne scars were enrolled. Acne scar lesions were treated with 1540-nm fractional photothermolysis (Starlux((TM)) 1540). Three treatment sessions were performed for each patient 4 weeks apart. Outcome assessments included the following four methods: (1) clinical evaluation of the photographs that were taken before and after the treatment; (2) comparison of the quality of life (QOL) of the patients before and after the treatment; (3) patients' satisfaction with the treatment; and (4) comparison of the quantity of collagen and elastic fibers in the skin biopsies before and 12 weeks after the last treatment. A mild to moderate clinical improvement was observed in most of the patients. Moreover, the QOL of all the patients improved, and all of them were satisfied with the results of the treatment. Significant collagen and elastic-fiber increases were also observed after the treatment, and side effects were limited to transient erythema and edema, which occurred in 50% of the patients. No severe side effect was observed. 1540 nm fractional photothermolysis is an effective and safe method for improving acne scar, even in Asian skin. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | The use of 1540 nm fractional photothermolysis for the treatment of acne scars in Asian skin: a pilot study | - |
dc.type | Article | - |
dc.identifier.doi | 10.1111/j.1600-0781.2009.00430.x | - |
dc.identifier.bibliographicCitation | PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, v.25, no.3, pp 138 - 142 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000265511900005 | - |
dc.identifier.scopusid | 2-s2.0-65449135864 | - |
dc.citation.endPage | 142 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 138 | - |
dc.citation.title | PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE | - |
dc.citation.volume | 25 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | acne scar | - |
dc.subject.keywordAuthor | Starlux((TM)) 1540 | - |
dc.subject.keywordAuthor | 1540 nm fractional photothermolysis | - |
dc.subject.keywordPlus | LASER PHOTOTHERMOLYSIS | - |
dc.subject.keywordPlus | COMPLICATIONS | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.